Cost Estimations

Allen Dobson, Ph.D.

Senior Vice President, The Lewin Group, Inc.


Public Comment

Mark Schnizler, Ph.D., Graduate Program in Health Administration, Washington University, St. Louis

National Kidney Foundation: transAction Council

Dr. Andrew Silverman, Pharm.D.

Pharmacotherapy Specialist, Transplantation Services, Tampa General Hospital


General Discussion and Questions



Other Participants and Observers: Clifford Amend, M.D., Blue Cross and Blue Shield of Maryland; Dolph Chianchiano, National Kidney Foundation; Joseph Chin, M.D., Health Care Financing Administration; Julia Christensen, Congressional Budget Office; Lauren Geyer, Health Care Financing Administration; Melody Hughson, Hoffman-La Roche; Kim Jackson, Transplant Recipients International Organization; Jesse Kerns, M.P.P., The Lewin Group, Inc.; Lizzy O’Hara, Congressman Boggs’s Office; Linda Ohler, National Association of Transplant Coordinators; Jackie Sheidan, Health Care Financing Administration; Alex Shipman, Covance; Andy Swire, Pharmaceutical Research and Manufacturers of America; Patricia Weitzkittel, American Nephrology Nurses Association; Stacey Windham, Congressman Canady’s Office; Troy Zimmerman, National Kidney Foundation.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement